Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep106 | Adrenal and Cardiovascular Endocrinology | ECE2022

11-deoxycorticosterone producing adrenal hyperplasia as a very unusual cause of endocrine hypertension: case report and systematic review of the literature

Roca Queralt Asla , Simo Helena Sarda , Puertas Enrique Lerma , Hanzu Felicia Alexandra , Urgell Rull Eulalia , Perez Garcia Jose Ignacio , Youdale Susan Webb , Maso Ana Aulinas

11-deoxycorticosterone (DOC) is an aldosterone precursor synthesized from progesterone and converted to corticosterone in the adrenal cortex. DOC overproduction due to an adrenal lesion is a very rare cause of mineralocorticoid-induced hypertension. The objective of this study is to provide the most relevant clinical features that clinicians dealing with patients presenting with the hallmarks of hypertension due to DOC-producing adrenal lesions should be aware of. We report a ...

ea0099rc5.5 | Rapid Communications 5: Pituitary and Neuroendocrinology | Part I | ECE2024

CRH-stimulated oxytocin in patients with hypopituitarism and hypothalamic damage: A randomized, single-blind, crossover, placebo-controlled trial

Asla Roca Queralt , Garrido Sanchez Maite , Urgell Rull Eulalia , Terzan Molina Silvia , Santos Vives Alicia , Fernandez Miro Merce , Varghese Nimmy , Atila Cihan , Calabrese Anna , Biagetti Betina , Christ-Crain Mirjam , Eckert Anne , Webb Susan M , Lawson Elizabeth A , Aulinas Maso Ana

Introduction: Disruption of the hypothalamic/pituitary axes may lead to hypopituitarism. Anterior pituitary deficiencies (APD) and arginine-vasopressin deficiency (AVP-D) are well established and are treated with hormone replacement. Over the last decade, preliminary studies support the presence of an oxytocin (OXT)-deficient state that might be clinically relevant in patients with hypopituitarism and hypothalamic damage (HHD). Therefore, identifying a provocative test to diag...

ea0032p696 | Neuroendocrinology | ECE2013

Evaluation of the efficacy of midnight salivary cortisol plus dexamethasone suppression test as screening for the diagnosis of hypercortisolism within an at-risk population

Leal-Cerro Alfonso , Madrazo-Atutxa Ainara , Garcia-Arnes Juan , Lamas-Oliveira Cristina , Boronat-Cort Mauro , Lillo Juan A , Fajardo Carmen , Urgell-Rull Eulalia , Salvador Javier , Salinas Isabel , Bernabeu Ignacio , Paramo Concha , Webb Susan , Torres-Vela Elena , Diaz Angel , Aller Javier , Leon-Justel Antonio

Introduction: Endogenous Cushing’s syndrome (CS) is a rare, infradiagnosed and severe disease that carries high morbidity and mortality. Delays in treatment initiation reduce reversibility of symptoms and increase mortality rate. Current gold standard for screening, 24 h urinary free cortisol, has a low reproducibility and specificity, and sampling is complicated. Midnight salivary cortisol (MSVC) determination is considered an easy and cheap test. We intend to assess its...